ADORA2A and neoplasm: Additionally, while this review has mostly focused on the role of A2aR signaling on T cells, it is clear that A2aR blockade will also promote tumor immunotherapy through its effect of NK cells, as well as myeloid derived suppressor cells, and tumor-associated macrophages.